[Diucifon and dimocifon in the combined therapy of leprosy (14-year observation)].
Goloshchapov
N M
NM
Bazurov
G I
GI
Khromova
E B
EB
Steklovskiĭ
V K
VK
Goloshchapova
F N
FN
D002986:Clinical Trials as Topic; D003622:Dapsone / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage*; D007918:Leprosy / Q000188:drug therapy*; D013450:Sulfones / Q000008:administration & dosage*; D013997:Time Factors; D014498:Uracil / Q000008:administration & dosage / Q000031:analogs & derivatives*
D004338:Drug Combinations; D007917:Leprostatic Agents; D013450:Sulfones; C023367:diucifon; D014498:Uracil; C040893:dapsone, methyluracil drug combination; D003622:Dapsone
Diutsifon i dimotsifon v kombinirovannoĭ terapii lepry (14-letnee nabliudenie).